Roundup Lawsuit Status: SCOTUS Ruling & Settlement (2026)

Roundup litigation is genuinely two different things happening at once, and conflating them is the most common way “Roundup lawsuit update” content misleads readers. A Supreme Court ruling in June 2026 narrowed one legal theory without ending the litigation. Separately, and on its own track, a proposed multibillion-dollar Missouri class settlement is still working through a contested approval process. Neither development means what a lot of headline coverage implied.

Quick answer: The federal litigation is MDL No. 2741 before Judge Vince Chhabria in the Northern District of California, with roughly 3,900 cases pending. On June 25, 2026, the Supreme Court ruled 7-2 that federal law preempts state-law failure-to-warn claims — narrowing, not ending, the litigation, since design-defect and negligence claims can still proceed. Separately, a proposed $7.25 billion Missouri state-court class settlement covering current and future non-Hodgkin lymphoma claims received preliminary approval in March 2026, was contested and briefly pulled toward the federal MDL, and was sent back to Missouri state court — its final fairness hearing is not yet finalized. On the science: the WHO’s cancer research arm and the U.S. EPA have reached different conclusions about glyphosate’s carcinogenicity, and no single consensus classification exists.

Two Tracks, Not One Case

The federal MDL. Individual lawsuits filed in federal courts nationwide were consolidated as MDL No. 2741 before Judge Vince Chhabria in the Northern District of California. Each plaintiff keeps an individual case — this is the ordinary MDL structure, not a class action.

The Missouri class settlement. Separately, a proposed $7.25 billion settlement was filed and received preliminary approval in Missouri state court (Cole County) in March 2026, structured as a class resolution of current and future non-Hodgkin lymphoma claims over roughly 21 years. Objectors argued it belonged with the federal MDL instead and had it removed there; Judge Chhabria was reportedly openly critical of the deal, and it was remanded back to Missouri state court in June 2026. As of August 6, 2026, the Missouri court rescheduled the final fairness hearing to September 14, 2026, and moved the opt-out deadline to August 21, 2026. Separately, roughly 30,000 additional Roundup lawsuits have been filed in Cole County since 2022, outside this settlement structure.

These two tracks can move independently — a ruling affecting the MDL doesn’t automatically apply to the Missouri settlement class, and vice versa.

What the Supreme Court Actually Decided

On June 25, 2026, the Court ruled 7-2 that the federal pesticide labeling statute (FIFRA) preempts state-law failure-to-warn claims against Roundup — the theory that the product’s label should have carried a cancer warning. The ruling does not address or foreclose claims based on defective design or ordinary negligence, which remain available and are what most surviving suits are expected to rely on going forward. A narrowed legal theory is not the same as a resolved case, and large verdicts on the remaining theories are still realistic outcomes for individual plaintiffs.

The Missouri Settlement Isn’t Final

As of this guide’s last update, the Missouri class settlement has cleared preliminary approval and survived a detour toward the federal MDL, but it has not received final approval. Its fairness hearing — the hearing at which a judge decides whether to approve a class settlement as fair, reasonable and adequate — is scheduled for September 14, 2026, and Bayer has reserved the contractual right to withdraw from the deal if too many class members opt out by the August 21, 2026 deadline. Anyone inside the class deciding whether to opt out or accept the settlement’s terms is making a real, individual, largely irreversible decision that depends on their own diagnosis and exposure history — not something a general content page can resolve for you.

What the Science Actually Says

Two credible bodies have reached different conclusions, and neither has revised the other into agreement:

• The World Health Organization’s International Agency for Research on Cancer (IARC) classified glyphosate as “probably carcinogenic to humans” (Group 2A) based on its hazard-identification methodology.
• The U.S. Environmental Protection Agency has separately concluded glyphosate is “not likely to be carcinogenic to humans” under its registered, intended use — a risk-based assessment incorporating exposure levels, using a different methodology than IARC’s.

A jury verdict against a defendant applies yet a third standard — a preponderance of the evidence, filtered through rules on which expert causation testimony a court will even allow the jury to hear. That a jury found for a plaintiff in one trial, or that another jury didn’t, is a legal outcome under specific procedural rules. It is not the same statement as “the science has settled the question,” in either direction, and content asserting a firm scientific consensus here — either that Roundup definitively causes cancer or that it definitively doesn’t — is overstating what currently exists.

If You’re Considering or Already Have a Claim

• Your state’s statute of limitations, or discovery-rule accrual date, controls your own filing deadline — see our state-by-state statute of limitations guide. This litigation being large and ongoing doesn’t extend an individual deadline.
• If you’re part of the Missouri settlement class, the opt-out deadline is a real, consequential decision point — confirm with an attorney whether opting out or accepting the settlement terms fits your specific diagnosis and history before that date passes.
• If you’re not yet part of any claim, roughly 3,900 pending federal cases and an actively-being-finalized settlement class both indicate this litigation is not closed to new claimants the way some older mass torts are — but only an attorney reviewing your specific facts can confirm your deadline and options.

Sources & Further Reading

• U.S. District Court, Northern District of California — docket for MDL No. 2741, In re: Roundup Products Liability Litigation
• Supreme Court ruling on FIFRA preemption of failure-to-warn claims, June 25, 2026 (the Durnell case)
• Circuit Court of Cole County, Missouri — docket for the proposed $7.25 billion class settlement and its fairness hearing
• International Agency for Research on Cancer (IARC), glyphosate monograph, and U.S. EPA glyphosate registration review — for the two divergent regulatory assessments described above
• See our explainer on how mass tort litigation actually works for what “MDL,” “fairness hearing” and “opt out” mean in practice
• To check your exposure and diagnosis against the other active litigations covered on this site, use our mass tort eligibility screener